Guaifenesin and dextromethorphan liquid medication recalled for manufacturing control issues
Plastikon Healthcare LLC is recalling guaifenesin and dextromethorphan liquid medication (280,500 cups) distributed nationwide due to manufacturing control deviations in production.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: This is an FDA Class II recall for manufacturing control deviations. Although no illnesses or injuries have been reported, the failure to adequately control manufacturing processes in a drug product qualifies as a risk-of-harm product per the rubric.
Plain-English summary
Plastikon Healthcare LLC is recalling GUAIFENESIN AND DEXTROMETHORPHAN 100 mg-10 mg/5 mL liquid medication distributed nationwide. The product is packaged in 5 mL cups (10 cups per tray, 10 trays per carton) and is labeled for institutional use only.
The recall was initiated because the products were manufactured under conditions that did not adequately control manufacturing processes (CGMP deviations). This means the facility's quality control procedures did not ensure consistent product standards during manufacturing.
The recall affects approximately 280,500 cups across multiple lot numbers with expiration dates ranging from September 2022 through March 2024. Affected lot numbers include 20091A, 20104A, 21013A, 21041A, 21102A, 21121A, 21127A, 22003A, 22007A, and 22016A.
The recalled product
- Product
- GUAIFENESIN AND DEXTROMETHORPHAN 100 mg-10 mg/5 mL, 5 mL cup, packaged in 10 cups per tray, 10 trays per carton, For Institutional Use Only, Major Pharmaceuticals, 17177 N Laurel Park Dr. Suite 233, Livonia, MI 48152. NDC 0904-6844-70
- Manufacturer
- Plastikon Healthcare LLC
- Category
- Drug
- Hazard
- cgmp-deviation
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (18)
- Lot # 20091A
- EXP Sep. 2022
- 20104A
- EXP Nov. 2022
- 21013A
- EXP Feb. 2023
- 21041A
- EXP Apr. 2023
- 21102A
- EXP Sep. 2023
- 21121A
- 21127A
- EXP Nov. 2023
- 22003A
- 22007A
- EXP Jan. 2024
- 22016A
- EXP Mar. 2024
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateCorlanor Ivabradine Tablets Recalled for Foreign Substance Contamination
FDA (Drugs) · 2026-07-01
- ModerateSensipar cinacalcet hydrochloride tablets recalled for CGMP deviations
FDA (Drugs) · 2026-07-01
- ModerateSensipar Cinacalcet Tablets Recalled Due to CGMP Deviations
FDA (Drugs) · 2026-07-01
- ModerateSensipar (Cinacalcet Hydrochloride) Tablets Recalled for CGMP Deviations
FDA (Drugs) · 2026-07-01